Lectenz® Bio targets glycan biomarkers of clinical significance for investigation and to leverage them for advancing human health. Glycans are important biomarkers in diseases and drug development and are frequently low abundance biomarkers. Unfortunately, they are difficult to detect with current reagents. The company’s mission is to develop technologies that enable novel glycoscience applications, provide services that enhance glycan biomarker detection, deliver tools that advance research and clinical applications.